Post Menopause Panel
Post Menopause Panel checks key hormones, thyroid signals, lipids, glucose control, and inflammation to help you interpret symptoms and risks together.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a lab panel, not a single hormone test. In one blood draw, the Post Menopause Panel groups together several markers that commonly shift after menopause—sex hormones, thyroid signals, and cardiometabolic markers—so you can interpret your results as a pattern instead of chasing one number.
Do I need this panel?
You might consider the Post Menopause Panel if you are postmenopausal and you are trying to make sense of symptoms such as hot flashes, sleep disruption, mood changes, vaginal dryness, low libido, fatigue, or unexpected weight and body-composition changes. These symptoms can overlap with thyroid changes, insulin resistance, anemia, medication effects, and stress—so a bundled panel can help you avoid over-focusing on one hormone.
This panel can also be useful if you are thinking about or already using menopausal hormone therapy (MHT/HRT). Baseline testing helps you and your clinician discuss whether your symptoms match the expected postmenopausal hormone pattern, and it provides a starting point for monitoring safety markers like lipids and glucose control.
You may also want this panel if your family history or personal history raises cardiometabolic risk (high cholesterol, prediabetes, hypertension, gestational diabetes, PCOS history, or early menopause). After menopause, risk can rise even when you feel “fine,” and the most actionable information often comes from metabolic markers rather than sex hormones alone.
This panel supports clinician-directed care and shared decision-making. It does not diagnose menopause by itself or replace a medical evaluation for bleeding after menopause, severe symptoms, or new chest pain, shortness of breath, or neurologic symptoms.
Results can vary by lab method and reference range; your clinician may interpret trends and symptom context more than any single cutoff.
Lab testing
Ready to order the Post Menopause Panel?
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault lets you order the Post Menopause Panel as a single lab panel so you can see multiple related markers together. That matters after menopause because symptoms and risk often reflect a combination of sex-hormone changes, thyroid signaling, and metabolic health—not one isolated result.
After your blood draw, you can review your results in one place and use PocketMD to ask targeted questions like how your estradiol relates to FSH/LH, whether your thyroid pattern could be contributing to fatigue, or what your A1c and insulin suggest about insulin resistance. If you are on MHT/HRT, you can also use the panel to track changes over time and discuss whether your current plan aligns with your goals and safety markers.
If your results suggest you need more depth (for example, more detailed thyroid testing, androgen evaluation, or broader cardiometabolic risk markers), PocketMD can help you decide whether to expand testing or retest on a sensible cadence rather than reacting to online “optimal” numbers.
- One order, one draw: multiple postmenopause-relevant markers bundled together
- Designed for pattern-based interpretation (hormones + thyroid + cardiometabolic markers)
- PocketMD support for next-step questions and retesting strategy
Key benefits of the Post Menopause Panel
- Shows a postmenopausal hormone pattern by pairing estradiol with pituitary signals (FSH/LH) instead of relying on estradiol alone.
- Helps separate menopause-related symptoms from common look-alikes such as thyroid dysfunction, anemia, or blood-sugar dysregulation.
- Provides a baseline before starting or adjusting MHT/HRT so changes can be interpreted against your own starting point.
- Adds cardiometabolic markers (lipids and glucose control) that often become more important for long-term health after menopause.
- Flags patterns consistent with insulin resistance that can drive weight gain, fatigue, and triglyceride changes even without diabetes.
- Includes androgen-related markers that can clarify low libido, hair changes, or unexpected shifts in energy and body composition.
- Makes it easier to trend multiple related results over time, which is often more informative than a single snapshot.
What is the Post Menopause Panel?
The Post Menopause Panel is a bundled set of blood tests designed to look at the physiologic changes that commonly occur after menopause and the health risks that tend to rise in the postmenopausal years. Instead of ordering one hormone at a time, the panel groups markers into a few practical categories so your results can be interpreted as a whole.
After menopause, ovarian production of estradiol and progesterone drops, and the brain responds by increasing pituitary hormones (especially follicle-stimulating hormone, FSH, and luteinizing hormone, LH). That shift can be associated with vasomotor symptoms (hot flashes/night sweats), sleep disruption, and changes in vaginal and urinary tissues. At the same time, thyroid function and iron status can influence energy, hair, and weight, and metabolic markers (lipids, glucose, insulin) often become central to long-term cardiovascular and diabetes risk.
A key point: many postmenopausal symptoms are not specific. A “normal” estradiol for a postmenopausal reference range does not automatically explain fatigue, and a mildly abnormal thyroid marker does not automatically explain weight change. This panel is meant to give you a structured starting point for conversations with your clinician—especially if you are weighing lifestyle changes, MHT/HRT, or further evaluation.
What the hormone markers are looking for
In postmenopause, estradiol is typically low and FSH/LH are typically higher than in reproductive years. Progesterone is usually low unless you are taking it. Testosterone and DHEA-S (dehydroepiandrosterone sulfate) can vary widely; low levels may correlate with low libido or reduced well-being for some people, while higher-than-expected androgens can suggest other causes (such as medication effects or less common endocrine conditions).
Why thyroid and metabolic markers are included
Thyroid-stimulating hormone (TSH) and free T4 help screen for hypothyroidism or hyperthyroidism patterns that can overlap with menopause symptoms. Lipids, glucose, insulin, and A1c help estimate cardiometabolic risk and insulin resistance, which can shift after menopause due to changes in body composition, activity, sleep, and estrogen signaling.
How to use the panel if you are on MHT/HRT
If you use estrogen therapy, your estradiol result depends on the formulation (oral vs transdermal), timing of your last dose, and lab method. Progesterone results depend on whether you take oral micronized progesterone or another progestogen, and when you last took it. The most useful approach is often trend-based: compare your results to your baseline and to how you feel, while also monitoring safety-related markers like lipids and glucose.
What do my panel results mean?
Patterns that look low on this panel
A “low” pattern in a postmenopause panel usually means low estradiol (and often low progesterone) alongside higher FSH/LH, which is a common postmenopausal profile. If symptoms are prominent with this pattern, it can support a discussion about symptom-focused options (non-hormonal and hormonal) rather than pushing estradiol to a specific internet target. Low thyroid output patterns (for example, higher TSH with lower free T4) can also show up as “low” in a functional sense and may contribute to fatigue, constipation, cold intolerance, or hair changes. Low ferritin or low-normal hemoglobin can add another layer, especially if you have dietary restriction, prior heavy bleeding, or gastrointestinal issues.
Patterns that look optimal or well-balanced
An “optimal” pattern is one where your results fit your situation and goals: a clearly postmenopausal gonadotropin pattern (FSH/LH) with sex hormones that match whether you are on therapy, thyroid markers that are stable without a clear hypothyroid or hyperthyroid signal, and cardiometabolic markers that suggest lower risk (healthier LDL/non-HDL, triglycerides, A1c, and fasting glucose/insulin). If you are on MHT/HRT, “optimal” often means consistency over time—similar results on repeat testing with symptom control and no concerning shifts in lipids or glucose control.
Patterns that look high or out of range
A “high” pattern can mean different things depending on which category is elevated. Higher-than-expected estradiol for your therapy plan (or unexpectedly measurable estradiol when not using estrogen) may reflect timing of dosing, assay variation, or less commonly other sources of estrogen; interpretation should be individualized. Elevated androgens (testosterone or DHEA-S) are not typical for most postmenopausal people and can warrant a careful medication/supplement review and, if clearly high, clinician evaluation. On the cardiometabolic side, high LDL cholesterol, high triglycerides, elevated A1c, or higher fasting insulin can point toward increased cardiovascular risk or insulin resistance—often the most actionable “high” findings in postmenopause because they respond to lifestyle, weight, sleep, and sometimes medication.
Factors that influence your panel results
Timing and context matter with a multi-marker panel. MHT/HRT formulation and timing (oral vs patch/gel, last dose timing), biotin and other supplements, and certain medications (thyroid hormone, steroids, anti-androgens, statins, diabetes medications) can shift results. Acute illness, poor sleep, heavy training, and recent weight change can affect glucose, insulin, and inflammatory markers. Thyroid results can be influenced by iodine intake, thyroid antibodies (not always included in basic panels), and changes in binding proteins. Because this is a panel, the most reliable interpretation usually comes from looking for consistent patterns across categories and confirming unexpected findings with a repeat test or a more targeted add-on.
What’s included in this panel
- Tsh
- Estradiol
- Fsh
Frequently Asked Questions
Do I need to fast for the Post Menopause Panel?
Fasting is often recommended because the panel commonly includes fasting glucose, fasting insulin, and triglycerides, which are easiest to interpret when you have not eaten for 8–12 hours. If you cannot fast, you can still test, but note it in your interpretation and consider repeating fasting markers if results are borderline or unexpected.
Can this panel confirm that I am postmenopausal?
A typical postmenopausal pattern is low estradiol with higher FSH (and often higher LH), but menopause is primarily a clinical diagnosis based on your menstrual history and symptoms. If you have had a hysterectomy, are using hormones, or have irregular bleeding patterns, labs can be more helpful—but they still need clinician interpretation.
If I am on estrogen or progesterone therapy, will the hormone results be “accurate”?
They can be accurate, but they reflect your therapy and timing. Estradiol levels vary by route (oral vs transdermal) and by when you last used your medication. Progesterone levels vary by formulation and timing as well. The most useful approach is to test consistently (same timing relative to dosing) and focus on trends plus symptom response and safety markers.
Why does a postmenopause panel include cholesterol and blood sugar markers?
After menopause, cardiometabolic risk often becomes a bigger driver of long-term health than sex-hormone levels alone. Lipids, A1c, glucose, and insulin help identify insulin resistance and cardiovascular risk patterns that can be addressed with lifestyle changes and, when appropriate, medication.
How should I interpret results when some markers are normal and others are abnormal?
That is common with panels. Start by grouping results: (1) sex-hormone pattern (estradiol with FSH/LH), (2) thyroid pattern (TSH with free T4), and (3) cardiometabolic pattern (lipids, A1c, glucose/insulin, inflammation). A single outlier may be timing, lab variation, or a temporary factor; a consistent pattern across related markers is more meaningful and may guide next steps.
Is it better to order this panel or order individual tests?
A panel is usually better when you want a coherent picture and you do not want to guess which single test will be most informative. Individual tests can make sense for targeted follow-up (for example, adding thyroid antibodies, ApoB, or a more detailed androgen workup) once you see your baseline pattern.
How often should I repeat the Post Menopause Panel?
It depends on your goals. If you are establishing a baseline, repeating in 3–6 months after a meaningful change (starting or adjusting therapy, major lifestyle changes, weight change) can be reasonable. If you are stable and monitoring long-term risk, many people retest annually, with more frequent follow-up for abnormal lipids, A1c, or thyroid results.